Tolbutamide

甲苯磺丁脲

Report date: 2023/02/27 09:46:58
NME

Base Information

Drug NameTolbutamide
Drug Alias Nametolbutamide甲糖宁tolbutamida甲苯磺胺丁脲tolbutamidum +[8] 
ClassificationSmall molecules > Carbohydrate
Mechanisms of ActionSulfonylurea receptor 1 inhibitors
TargetsSulfonylurea receptor 1
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsDiabetes Mellitus, Type 2
Approved Indications in ChinaDiabetes Mellitus, Type 2
Original Approved Country/TerritoryUnited States
Original Approved Date1957/05/31
Country/TerritoryUnited StatesUnited KingdomMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesChangzhou Pharmaceutical FactoryChelonia Healthcare Ltd
Inactive CompaniesPharmacia & Upjohn
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeA10BB03V04CA01
Related LinksWikipediaDrugBankKEGG